DE69309269D1 - Monomere und dimere Peptide, ihre Verwendung zum Schutz von Zellen und ihre Herstellungsverfahren - Google Patents
Monomere und dimere Peptide, ihre Verwendung zum Schutz von Zellen und ihre HerstellungsverfahrenInfo
- Publication number
- DE69309269D1 DE69309269D1 DE69309269T DE69309269T DE69309269D1 DE 69309269 D1 DE69309269 D1 DE 69309269D1 DE 69309269 T DE69309269 T DE 69309269T DE 69309269 T DE69309269 T DE 69309269T DE 69309269 D1 DE69309269 D1 DE 69309269D1
- Authority
- DE
- Germany
- Prior art keywords
- asx
- fragment
- monomeric
- production processes
- protecting cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 4
- 238000004519 manufacturing process Methods 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 239000012634 fragment Substances 0.000 abstract 4
- 239000000126 substance Substances 0.000 abstract 3
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 abstract 1
- YPIGGYHFMKJNKV-UHFFFAOYSA-N N-ethylglycine Chemical compound CC[NH2+]CC([O-])=O YPIGGYHFMKJNKV-UHFFFAOYSA-N 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 231100000433 cytotoxic Toxicity 0.000 abstract 1
- 230000001472 cytotoxic effect Effects 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/195—Chemokines, e.g. RANTES
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9205990A FR2691153B1 (fr) | 1992-05-18 | 1992-05-18 | Dodecapeptides monomere et dimere, utilisation en tant qu'agents anti-megacaryocytaires. |
| PCT/FR1993/000483 WO1993023426A1 (fr) | 1992-05-18 | 1993-05-18 | Peptides monomeres et dimeres, utilisation en tant qu'agents cytoprotecteurs et procede de preparation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE69309269D1 true DE69309269D1 (de) | 1997-04-30 |
| DE69309269T2 DE69309269T2 (de) | 1997-10-30 |
Family
ID=9429874
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE69309269T Expired - Fee Related DE69309269T2 (de) | 1992-05-18 | 1993-05-18 | Monomere und dimere Peptide, ihre Verwendung zum Schutz von Zellen und ihre Herstellungsverfahren |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP0642531B1 (de) |
| JP (1) | JPH07506587A (de) |
| AT (1) | ATE150766T1 (de) |
| DE (1) | DE69309269T2 (de) |
| FR (1) | FR2691153B1 (de) |
| WO (1) | WO1993023426A1 (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2774990B1 (fr) * | 1998-02-16 | 2000-07-28 | Inst Vaisseaux Et Du Sang | Nouveaux peptides, utilisation en therapeutique et compositions pharmaceutiques les renfermant |
| JP2003509478A (ja) | 1999-09-21 | 2003-03-11 | エモリー・ユニバーシティ | 血小板関連障害を処置する方法および組成物 |
| FR2811991B1 (fr) * | 2000-07-19 | 2003-01-17 | Univ Bordeaux 1 | Pf-4 mute, ses fragments et peptides de fusion mutes, leurs analogues, les sequences d'adn, adnc et arnm correspondantes, et leur utilisation dans l'inhibition de l'angiogenese |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5185323A (en) * | 1988-03-31 | 1993-02-09 | Temple University | Suppression of megakaryocytopoiesis employing platelet factor 4 antimaturation factor |
| ATE124421T1 (de) * | 1989-09-25 | 1995-07-15 | Genetics Inst | Verfahren zur wachstumshemmung von stammzellen. |
| WO1992002240A2 (en) * | 1990-07-27 | 1992-02-20 | Repligen Corporation | Novel methods and compositions for treatment of angiogenic diseases |
-
1992
- 1992-05-18 FR FR9205990A patent/FR2691153B1/fr not_active Expired - Fee Related
-
1993
- 1993-05-18 AT AT93910135T patent/ATE150766T1/de not_active IP Right Cessation
- 1993-05-18 WO PCT/FR1993/000483 patent/WO1993023426A1/fr active IP Right Grant
- 1993-05-18 DE DE69309269T patent/DE69309269T2/de not_active Expired - Fee Related
- 1993-05-18 EP EP93910135A patent/EP0642531B1/de not_active Expired - Lifetime
- 1993-05-18 JP JP5519954A patent/JPH07506587A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| DE69309269T2 (de) | 1997-10-30 |
| WO1993023426A1 (fr) | 1993-11-25 |
| FR2691153A1 (fr) | 1993-11-19 |
| JPH07506587A (ja) | 1995-07-20 |
| EP0642531A1 (de) | 1995-03-15 |
| FR2691153B1 (fr) | 1995-06-30 |
| ATE150766T1 (de) | 1997-04-15 |
| EP0642531B1 (de) | 1997-03-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Sottrup-Jensen et al. | Domain structure of human α2‐macroglobulin: Characterization of a receptor‐binding domain obtained by digestion with papain | |
| Correas et al. | Identification of the functional site of erythrocyte protein 4.1 involved in spectrin-actin associations. | |
| Donermeyer et al. | Binding to Ia protects an immunogenic peptide from proteolytic degradation. | |
| Reed et al. | Sequence of residues 400--403 of bovine serum albumin. | |
| Kosfeld et al. | Identification of a new cell adhesion motif in two homologous peptides from the COOH-terminal cell binding domain of human thrombospondin. | |
| ATE425181T1 (de) | Therapeutische zusammensetzungen aus antikorper und antisens nukleinsäuren gegen serrate | |
| AU625801B2 (en) | Novel inhibitors of platelet binding | |
| ATE348883T1 (de) | Zusammensetzungen und verfahren mit analogen von g-csf | |
| KR940005670A (ko) | 펩티드 | |
| KR19990077344A (ko) | 합성 il-10 동족체 | |
| AU5963290A (en) | Inhibition of the n-end rule pathway in living cells | |
| Döring et al. | Identification and characterization of a TNFα antagonist derived from a monoclonal antibody | |
| KR980002066A (ko) | 변이형 인간 성장호르몬 및 그의 용도 | |
| KR920012440A (ko) | 인간 인터류킨-5 수용체 | |
| DE69309269D1 (de) | Monomere und dimere Peptide, ihre Verwendung zum Schutz von Zellen und ihre Herstellungsverfahren | |
| KR910009730A (ko) | 펩티드 | |
| ATE258061T1 (de) | Tri-, tetra-, penta- und polypeptide und ihre therapeutische verwendung als antidepressiva | |
| Yamashiro et al. | β‐ENDORPHIN: SYNTHESIS AND ANALGESIC ACTIVITY OF SEVERAL ANALOGS MODIFIED IN POSITIONS 2 AND 5 | |
| Or et al. | Improvements in the minimum binding sequence of C5a: examination of His-67 | |
| YAMASHIRO et al. | Synthesis and properties of dermorphin and an analog of β‐endorphin containing the dermorphin sequence | |
| AU707740B2 (en) | T cell epitopes of rye grass pollen allergen | |
| Weeden et al. | A retro‐inverso α‐melanocyte stimulating hormone analog with MC1R‐binding selectivity | |
| EP0151016A3 (de) | Antagonisten von Arginin-Vasopressin | |
| EP0189326A3 (de) | Derivate von Arginin-Vasopressin-Antagonisten | |
| AU642487B2 (en) | Neutrophil stimulating peptides |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition | ||
| 8339 | Ceased/non-payment of the annual fee |